Collegium is a Massachusetts-based specialty pharmaceutical company that develops and commercializes novel therapeutics for the treatment of chronic acute pain.
Business Model:
Revenue: $361.7M
Employees: 51-200
Address: 100 Technology Center Drive
City: Stoughton
State: MA
Zip: 02072
Country: US
Collegium is a Massachusetts-based specialty pharmaceutical company that develops and commercializes novel therapeutics for the treatment of chronic acute pain.
Contact Phone:
+17817133699
Contact Email:
Listed Exchange:
NASDAQ
IPO Date:
5/7/2015
IPO Valuation:
$236M
Ticker Symbol:
COLL
IPO Price:
$12/share
Amount Raised:
$80M
Opened: -/share
EBITDA | - |
Total Cash | - |
Total Debt | - |
Total Revenue | - |
Total Profit (Gross) | - |
PE Ratio | - |
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Name | Price |
---|---|---|
2/2022 | BioDelivery Sciences |
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|